Encapsulating peritoneal sclerosis: an unpredictable and devastating complication of peritoneal dialysis.
Am. J. Kidney Dis., Apr;47(4):697-712 (2006)
Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients.
Am. J. Kidney Dis., Jan;33(1):63-72 (1999)
C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients.
Am. J. Kidney Dis., Mar;35(3):469-76 (2000)
Extended daily dialysis: A new approach to renal replacement for acute renal failure in the intensive care unit.
Am. J. Kidney Dis., Aug;36(2):294-300 (2000)
Comparison and interpretation of urinalysis performed by a nephrologist versus a hospital-based clinical laboratory.
Am. J. Kidney Dis., Nov;46(5):820-9 (2005)
Extended daily dialysis vs. continuous hemodialysis for ICU patients with acute renal failure: a two-year single center report.
Int J Artif Organs., May;27(5):371-9 (2004)
Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients.
Am. J. Kidney Dis., Dec;30(6):923-7 (1997)
Initial therapy for uncomplicated hypertension: insights from the alphabetic maze of recent studies.
Minerva Med., Aug;94(4):215-27 (2003)
Fibrillary glomerulonephritis: a case report.
Am. J. Kidney Dis., Jul;18(1):131-3 (1991)
Initial antihypertensive therapy. What are the current drugs of choice?
Postgrad Med., Nov;110(5):39-40, 43-4, 47-8 passim (2001)
Co-Author, "Severity of chronic kidney disease as a risk factor for operative mortality in nonemergent patients in the California coronary artery bypass graft surgery outcomes reporting program."
The American Journal of Cardiology
Elsevier: "Therapy in Nephrology and Hypertension, 3rd Edition."
Co-Author, "Encapsulating peritoneal sclerosis: An unpredictable and devastating complication of peritoneal dialysis."
American Journal of Kidney Diseases